Re-appointment of Dr. Pooja Jain (DIN 00097037) as a Whole time Director for a term of five years.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Moongipa Capital Finance informed the stock exchange about resolutions passed at its 38th AGM held on September 25, 2025 via video conferencing. Shareholders approved increasing the company's Authorized Share Capital from Rs. 15.5 crore to Rs. 30 crore by creating an additional 1.45 crore equity shares of Rs. 10 each, along with a corresponding amendment to the MOA. Members also approved the re-appointment of Dr. Pooja Jain (DIN 00097037) as Whole-Time Director for a fresh five-year term starting October 14, 2025 to October 13, 2030; she has been on the board since October 14, 2015 and is related to Director Sanjay Jain (spouse) and CEO Piyush Jain (son). Additionally, M/s Kuldeep Dahiya & Associates were appointed as Secretarial Auditor for five years covering FY 2025-26 to FY 2029-30.
The authorized capital increase signals room for a future fund-raising or stock split, though no actual issue is announced yet. The re-appointment of the existing Whole-Time Director suggests continuity in management and no change in promoter-led leadership. Overall, this is a routine governance update with no immediate direct impact on share price or shareholder returns.